$14.80−0.91 (−5.79%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Personalis (PSNL) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 17.7% in FY25, net margin −116.7%. Worth your attention in FY25: Share count (+103.3%) and Capex step-up ($4.5M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼17.7%
69.6
FY21→FY25CAGR −5.0%/yr
Net income ($M)▲0.0%
−81.3
FY21→FY25CAGR —
Free cash flow ($M)▼69.9%
−79.5
capex stepped upCAGR —
Diluted EPS▲33.6%
−0.91
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+103.3%
43.9mn → 89.2mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex step-up
$4.5M
▲181% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-117¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 37.0% → 22.7%. Net margin -116.7% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 80,770.0 | 69,648.0 | 84,614.0 | 73,481.0 | 65,047.0 | 85,494.0 | ▼17.7% | −5.0% |
Cost of revenue | 67,276.0 | 53,871.0 | 57,789.0 | 55,273.0 | 51,697.0 | 53,837.0 | ▼6.8% | +0.0% |
Gross profit | 13,494.0 | 15,777.0 | 26,825.0 | 18,208.0 | 13,350.0 | 31,657.0 | ▼41.2% | −16.0% |
Research & development | 60,021.0 | 50,264.0 | 48,905.0 | 64,776.0 | 64,912.0 | 49,312.0 | ▲2.8% | +0.5% |
Selling, general & admin | 80,009.0 | 53,570.0 | 46,187.0 | 49,726.0 | 63,969.0 | 47,698.0 | ▲16.0% | +2.9% |
Total operating expenses | 140,030.0 | 103,834.0 | 95,092.0 | 128,144.0 | 128,881.0 | 97,010.0 | ▲9.2% | +1.7% |
Operating incomefeeds ROC rank | −126,536.0 | −88,057.0 | −68,267.0 | −109,936.0 | −115,531.0 | −65,353.0 | ▼29.0% | — |
Other income, net | 7,241.0 | 6,808.0 | −12,999.0 | 1,723.0 | 2,256.0 | 141.0 | — | — |
Pretax income | −119,295.0 | −81,249.0 | −81,266.0 | −108,213.0 | −113,275.0 | −65,212.0 | ▲0.0% | — |
Income tax | 33.0 | 21.0 | 18.0 | 83.0 | 40.0 | 14.0 | ▲16.7% | +10.7% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −119,328.0 | −81,270.0 | −81,284.0 | −108,296.0 | −113,315.0 | −65,226.0 | ▲0.0% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −1.17 | −0.91 | −1.37 | −2.25 | −2.48 | −1.49 | ▲33.6% | — |
Diluted shares (mn) | 107.21 | 89.24 | 59.25 | 48.18 | 45.70 | 43.89 | ▲50.6% | +19.4% |
| Margins | ||||||||
Gross margin5th pct in Healthcare | 16.7% | 22.7% | 31.7% | 24.8% | 20.5% | 37.0% | ▼9.1pp | −14.4pp |
Operating margin | −156.7% | −126.4% | −80.7% | −149.6% | −177.6% | −76.4% | ▼45.8pp | −50.0pp |
Net margin9th pct in Healthcare | −147.7% | −116.7% | −96.1% | −147.4% | −174.2% | −76.3% | ▼20.6pp | −40.4pp |
† TTM = trailing four quarters through 2026-09-30.
4 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Personalis' revenue last fiscal year?
Personalis reported revenue of $69.6M in fiscal 2025, down 17.7% from fiscal 2024.
What was Personalis' net income?
Personalis reported net income of −$81.3M in fiscal 2025, a net margin of −116.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

